The Discounted Cash Flow (DCF) valuation of Myriad Genetics Inc (MYGN) is (12.36) USD. With the latest stock price at 4.03 USD, the upside of Myriad Genetics Inc based on DCF is -406.6%.
Based on the latest price of 4.03 USD and our DCF valuation, Myriad Genetics Inc (MYGN) is a sell. selling MYGN stocks now will result in a potential gain of 406.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 9.9% | 8.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (29.24) - (8.02) | (12.36) |
| Upside | -825.6% - -299.1% | -406.6% |